Browse EyeWorld Weekly ophthalmology news on EyeWorld.org. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ Results from Phase 2a study evaluating glaucoma drop ➤ Enrollment complete for epi-on crosslinking trial ➤ Phase 2 clinical trial begins for investigational dry eye drop ➤ Enrollment complete for Phase 2 study to evaluate diabetic retinopathy treatment ➤ Phase 2b trial for wet AMD treatment begins enrollment ➤ ASCRS news and events
➤ Phase 2 trial with experimental geographic atrophy treatment shows preservation of visual function ➤ AI-enabled screening system receives FDA clearance ➤ Enrollment complete for study evaluating investigational first-line therapy for DME ➤ Updates from two retinitis pigmentosa trials ➤ ASCRS news and events
➤ FDA approves dry eye drop targeting tear evaporation ➤ Topline results from Phase 3 trial of eye drops for DME ➤ Investigational intravitreal gene therapy program introduced for geographic atrophy ➤ Phase 1 study for periocular drug for wet AMD and DME begins ➤ Commercial rights for uveitis treatment acquired ➤ ASCRS news and events
➤ Researchers discover new class of drugs that could treat retinal dystrophies ➤ Enrollment complete in Phase 1/2a study using novel dry eye treatment approach ➤ NDA submitted to FDA for investigational inflammation and pain treatment ➤ Study: first-in-human gene therapy trial for achromatopsia ➤ ASCRS news and events
➤ FDA approves ophthalmic spray for mydriasis ➤ FDA accepts NDA for travoprost intraocular implant ➤ FDA accepts supplemental BLA for treatment for macular edema ➤ FDA 510(k) clearance granted to green pattern laser photocoagulator ➤ NDA submitted for pain and inflammation nanoemulsion ➤ Positive clinical results from IOP-monitoring contact lens ➤ Study provides real-world data comparing MIGS using IRIS Registry ➤ FDA approves IOL positioning system ➤ ASCRS news and events
➤ Topline data from Phase 3 presbyopia drop trial ➤ Femtosecond laser for LASIK receives FDA clearance ➤ Enrollment complete for hydrophobic trifocal IOL trial ➤ Early results from clinical trial for dry eye therapy ➤ FDA clears IND application for clinical trial of therapy for X-linked retinoschisis ➤ Innovations in capsulotomy creation device ➤ Company acquisition news ➤ ASCRS news and events
➤ FDA approves new monofocal IOL ➤ Topline Phase 3 results for fixed-dose combination presbyopia drop ➤ Gene therapy trial produces positive Phase 1/2 data for Leber congenital amaurosis ➤ New data shows investigational compound protects endothelium for cataract patients undergoing Fuchs treatment ➤ ASCRS news and events
➤ First in-human, non-invasive femtosecond laser trabeculotomy data ➤ Special Protocol Assessment received for Phase 2b/3 trial for dry AMD treatment ➤ FDA gives clearance to IND for geographic atrophy treatment ➤ Positive preliminary data in trial for retinitis pigmentosa and Leber congenital amaurosis therapy ➤ Wet AMD treatment proceeds to Phase 2 trial ➤ ASCRS news and events
➤ Fast-Track Designation granted for persistent epithelial defect treatment ➤ Study: automated capsulotomy device and white cataracts ➤ Dose escalation complete for Phase 1/2 study evaluating an RP treatment ➤ Companies enter agreement for sustained-release glaucoma treatment ➤ ASCRS news and events
➤ FDA approves twice-daily use of presbyopia drop ➤ Study: drug approved for high blood pressure shows promise for blinding childhood disease ➤ Breakthrough device designation granted to investigational dry AMD therapy ➤ Positive topline results for Phase 2 study of retinitis pigmentosa treatment ➤ FDA approves pediatric enrollment in trial for retinitis pigmentosa and Leber congenital amaurosis ➤ ASCRS news and events
Get the latest ophthalmology news delivered to your inbox every Friday.